When does a scientific education truly make an impact?

Over 100 radiologists and radiologic technologists from across the Philippines participated in a session with Dr. Lawrence N. Tanenbaum, MD, FACR, titled MRI Contrast Agents: Safety and Choice - an in-depth discussion that extended beyond the contrast agents themselves to include the clinical decision-making processes involved in their application.

The discussion highlighted some daily questions faced by Imaging Teams:

• "Is it necessary to check creatinine and eGFR before each contrast-enhanced MRI?"

• "In what ways should renal function affect our decisions regarding contrast use?"

• "How does relaxivity impact diagnostic performance?"

• "When multiple agents are available, what factors should influence our choice?"

A common theme was that contrast selection should not rely on a single attribute. It requires considering clinical application, efficacy, safety profile, patient factors, relaxivity, dosage, and the diagnostic goal collectively.

Renal function sparked particularly meaningful discussions. A key takeaway was the importance of ensuring each step in the imaging process has a clear clinical purpose. When routine renal-function testing is unnecessary, a streamlined approach can enhance patient-centered care—facilitating timely imaging access, greater convenience, and more affordable care. By adhering to appropriate risk assessments and current guidelines, this approach maintains focus on delivering the diagnostic information essential for informed decision-making for each patient.

Relaxivity was discussed in the same context: as one of several factors influencing enhancement and diagnostic performance, alongside dosage, acquisition technique, timing, field strength, motion control, safety considerations, and the clinical question being addressed. The conversation extended beyond the lecture.

Participants' reflections underscored the discussion's relevance, with patient safety, renal function, contrast selection, relaxivity, enhancement, and GBCA safety emerging as key learning points. The exchange also paved the way for deeper discussions on renal impairment, dose optimization, standardized protocols, MRA timing, pediatric imaging, and managing increasingly complex patient profiles.

This perhaps encapsulates the evening's most significant message: The question is not merely, “Which contrast agent is best?” but rather, “What is the right contrast decision for this patient, this examination, and this diagnostic objective?”

The true value of medical education lies not only in what clinicians learn but in how it changes their thinking when they return to their patients.

Written by (with AI-assisted editing):

Honellen P. Claudio, RMT

Customer Success, Proxymm Science